T-Cell Therapy Market Size to Hit $21+ Billion with Booming CAGR Value of 20.7% by 2028 | The Insight Partners
October 20, 2022 09:22 ET
|
The Insight Partners
New York, Oct. 20, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners latest study on "T-cell Therapy Market Size, Share, Trends, Growth Strategy and Forecast to 2028 – COVID-19 Impact and...
Global Sports Nutrition and Supplements Market Anticipated to Generate a Revenue of $35,350.0 Million and Rise at a CAGR of 12.9% during the Forecast Period 2019-2026 | Research Dive
September 13, 2022 09:01 ET
|
Research Dive
New York, USA, Sept. 13, 2022 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global sports nutrition and supplements market is envisioned to generate a revenue of...
Innovative Spinal Biomaterial Demonstrates Early Healing in Retrospective Study
September 08, 2022 09:00 ET
|
DiFusion, Inc.
AUSTIN, Texas, Sept. 08, 2022 (GLOBE NEWSWIRE) -- DiFusion, Inc., an Austin, Texas-based leader in biomaterial technological innovation focused on introducing bioactive polymers in spinal and...
Global Systemic Lupus Erythematosus (SLE) Market Report 2022-2026: Featuring Pfizer, AstraZeneca, GlaxoSmithKline and Others
June 29, 2022 06:48 ET
|
Research and Markets
Dublin, June 29, 2022 (GLOBE NEWSWIRE) -- The "Global Systemic Lupus Erythematosus (SLE) Market: Analysis By Product Type, By Route of Administration, By End User, By Region Size and Trends with...
Aditxt Engages IBN (InvestorBrandNetwork) To Bolster Its Corporate Communications Efforts
June 09, 2022 08:30 ET
|
InvestorBrandNetwork (IBN)
LOS ANGELES, June 09, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – Aditxt, Inc. (“Aditxt” or “the Company”) (NASDAQ: ADTX), a biotech innovation company, today announces it has selected the corporate...
Global Immune Monitoring Solutions Market - Forecast to 2027
March 23, 2022 09:00 ET
|
Global Market Estimates
Brooklyn, New York, March 23, 2022 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global Immune Monitoring Solutions Market is projected to...
BioAegis’ Novel Host-directed Human Protein for Inflammatory Diseases Geared for Growth in 2022
January 24, 2022 15:52 ET
|
BioAegis Therapeutics
NORTH BRUNSWICK, N.J., Jan. 24, 2022 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc., a clinical-stage, private company developing therapies for infectious, inflammatory and degenerative diseases...
Global Oncology Targeted Immunotherapy Market Research Report 2021: Developments in Biotechnology Platforms Leading to Increasing Immuno-oncology Applications
January 20, 2022 04:08 ET
|
Research and Markets
Dublin, Jan. 20, 2022 (GLOBE NEWSWIRE) -- The "Targeted Immunotherapy in Oncology" report has been added to ResearchAndMarkets.com's offering. This research service investigates technologies that...
BioAegis Therapeutics to Present “Conquering Pneumonia and Systemic Inflammation with a Human Protein,” at the MACRO Trends Investor Conference in Belgium
October 29, 2021 15:44 ET
|
BioAegis Therapeutics
NORTH BRUNSWICK, N.J., Oct. 29, 2021 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc., a clinical stage, private company developing therapies for infectious, inflammatory, and degenerative diseases...
Researchers Discover Previously Unknown Role of BioAegis’ Therapeutic Gelsolin as Key Signaling Protein Vital for Regulating Immune Cell Inflammatory Response
September 28, 2021 11:17 ET
|
BioAegis Therapeutics
This biological phenomenon, quorum sensing in macrophages, regulates the transition of cells from inflammatory to healing phenotype. NORTH BRUNSWICK, New Jersey, Sept. 28, 2021 (GLOBE NEWSWIRE) --...